Articles by Stan Bernard, MD - Pharmaceutical Executive

ADVERTISEMENT

Articles by Stan Bernard, MD

Are You Trained to Compete and Win?

With the impact of the sales rep on revenue flows in decline, it's time to beef up training
Feb 1, 2011

With the impact of the sales rep in decline, it's time to beef up training for other pharma functions to fill the gap in a competitive marketplace

Decisive Strategy Wins the Market

A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way
Oct 1, 2010

A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way

Big Pharma's Most Feared Competitor

Jul 1, 2010

Teva Pharmaceuticals has emerged as the industry's most formidable foe.

3D Competitive Analysis

As the pharma industry transitions to a more challenging product life cycle profile, companies need to employ innovative approaches for assessing competitors, stakeholders, and markets
Apr 1, 2010

Companies need to employ 3D analysis to assess markets, stakeholders, and competitors

Think Different

Oct 1, 2009

Game-changers can create competitive advantages for pharmaceutical companies and products.

Forget Brand vs. Brand—This is War

Jul 1, 2009

Increasingly, pharma companies are expanding from brand vs. brand to battle at the franchise, portfolio, and corporate levels.

When Sharks Attack

Apr 1, 2009

Launching a product? Your competition likely plans to interfere. Here's how to counter a counter-launch.

Pharma vs. Pharma

Jan 1, 2009

Every industry has a life cycle, and pharma's has just entered its competitive stage. Here's how to prepare.

Consumerization: Pandora's Pillbox

By going direct-to-consumer, the industry unwittingly unleashed a swarm of opportunities for other players to enter the pharmaceutical fray. And they made the most of it. Now, a decade later, pharma is feeling the fallout in consumer trust and product value. It's time to take back control.
Jun 1, 2007

To harness consumerization to improve the industry's image and enhance the value of its products, pharma leaders need to focus on the "Four Cs": commitment, choice, collaboration, and customization

ADVERTISEMENT

Click here